Bronchiolitis obliterans organizing pneumonia: Difference between revisions
Jump to navigation
Jump to search
imported>Joe Quick m (subpages) |
imported>Chunbum Park No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
'''Bronchiolitis obliterans organizing pneumonia''' (BOOP) is defined as "A disease formerly considered a form of interstitial pneumonia. Its etiology is obscure but it may be associated with toxic fumes, infection, and connective tissue disease. Clinical symptoms include cough, dyspnea and influenza-like symptoms with the development of the usual interstitial pneumonia in many cases. Obstructive symptoms are limited to smokers. There are patchy polypoid masses of intra-alveolar granulation tissue in small airway lumina and alveolar ducts. "Organizing" refers to unresolved pneumonia (in which the alveolar exudate persists and eventually undergoes fibrosis) in which fibrous tissue forms in the alveoli."<ref>{{cite web |url=http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&tool=UTHSCSAplugins&db=mesh&term=Bronchiolitis%20Obliterans%20Organizing%20Pneumonia |title=Bronchiolitis obliterans organizing pneumonia |accessdate=2007-10-29 |author=National Library of Medicine |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote=}}</ref> | '''Bronchiolitis obliterans organizing pneumonia''' (BOOP) is defined as "A disease formerly considered a form of interstitial pneumonia. Its etiology is obscure but it may be associated with toxic fumes, infection, and connective tissue disease. Clinical symptoms include cough, dyspnea and influenza-like symptoms with the development of the usual interstitial pneumonia in many cases. Obstructive symptoms are limited to smokers. There are patchy polypoid masses of intra-alveolar granulation tissue in small airway lumina and alveolar ducts. "Organizing" refers to unresolved pneumonia (in which the alveolar exudate persists and eventually undergoes fibrosis) in which fibrous tissue forms in the alveoli."<ref>{{cite web |url=http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&tool=UTHSCSAplugins&db=mesh&term=Bronchiolitis%20Obliterans%20Organizing%20Pneumonia |title=Bronchiolitis obliterans organizing pneumonia |accessdate=2007-10-29 |author=National Library of Medicine |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote=}}</ref> | ||
{{editintro}} | |||
==Cause/etiology== | ==Cause/etiology== | ||
Most cases are idiopathic, but BOOP can be an [[adverse drug reaction]], can also be post-infectious, and can be associated with rheumatologic diseases.<ref name="pmid11176728">{{cite journal |author=Epler GR |title=Bronchiolitis obliterans organizing pneumonia |journal=Arch. Intern. Med. |volume=161 |issue=2 |pages=158–64 |year=2001 |pmid=11176728 |doi= |issn=|url=http://archinte.ama-assn.org/cgi/content/full/161/2/158}}</ref> Culprit drugs include [[rituximab]].<ref name="pmid16948177">{{cite journal |author=Biehn SE, Kirk D, Rivera MP, Martinez AE, Khandani AH, Orlowski RZ |title=Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma |journal=Hematological oncology |volume=24 |issue=4 |pages=234–7 |year=2006 |pmid=16948177 |doi=10.1002/hon.799 |issn=}}</ref><ref name="pmid16194900">{{cite journal |author=Macartney C, Burke E, Elborn S, ''et al'' |title=Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim |journal=Leuk. Lymphoma |volume=46 |issue=10 |pages=1523–6 |year=2005 |pmid=16194900 |doi=10.1080/10428190500144615 |issn=}}</ref> | Most cases are idiopathic, but BOOP can be an [[adverse drug reaction]], can also be post-infectious, and can be associated with rheumatologic diseases.<ref name="pmid11176728">{{cite journal |author=Epler GR |title=Bronchiolitis obliterans organizing pneumonia |journal=Arch. Intern. Med. |volume=161 |issue=2 |pages=158–64 |year=2001 |pmid=11176728 |doi= |issn=|url=http://archinte.ama-assn.org/cgi/content/full/161/2/158}}</ref> Culprit drugs include [[rituximab]].<ref name="pmid16948177">{{cite journal |author=Biehn SE, Kirk D, Rivera MP, Martinez AE, Khandani AH, Orlowski RZ |title=Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma |journal=Hematological oncology |volume=24 |issue=4 |pages=234–7 |year=2006 |pmid=16948177 |doi=10.1002/hon.799 |issn=}}</ref><ref name="pmid16194900">{{cite journal |author=Macartney C, Burke E, Elborn S, ''et al'' |title=Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim |journal=Leuk. Lymphoma |volume=46 |issue=10 |pages=1523–6 |year=2005 |pmid=16194900 |doi=10.1080/10428190500144615 |issn=}}</ref> | ||
Revision as of 16:53, 5 January 2008
Bronchiolitis obliterans organizing pneumonia (BOOP) is defined as "A disease formerly considered a form of interstitial pneumonia. Its etiology is obscure but it may be associated with toxic fumes, infection, and connective tissue disease. Clinical symptoms include cough, dyspnea and influenza-like symptoms with the development of the usual interstitial pneumonia in many cases. Obstructive symptoms are limited to smokers. There are patchy polypoid masses of intra-alveolar granulation tissue in small airway lumina and alveolar ducts. "Organizing" refers to unresolved pneumonia (in which the alveolar exudate persists and eventually undergoes fibrosis) in which fibrous tissue forms in the alveoli."[1]
[]
Cause/etiology
Most cases are idiopathic, but BOOP can be an adverse drug reaction, can also be post-infectious, and can be associated with rheumatologic diseases.[2] Culprit drugs include rituximab.[3][4]
Treatment
Prednisone is the first choice treatment.[2]
References
- ↑ National Library of Medicine. Bronchiolitis obliterans organizing pneumonia. Retrieved on 2007-10-29.
- ↑ 2.0 2.1 Epler GR (2001). "Bronchiolitis obliterans organizing pneumonia". Arch. Intern. Med. 161 (2): 158–64. PMID 11176728. [e]
- ↑ Biehn SE, Kirk D, Rivera MP, Martinez AE, Khandani AH, Orlowski RZ (2006). "Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma". Hematological oncology 24 (4): 234–7. DOI:10.1002/hon.799. PMID 16948177. Research Blogging.
- ↑ Macartney C, Burke E, Elborn S, et al (2005). "Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim". Leuk. Lymphoma 46 (10): 1523–6. DOI:10.1080/10428190500144615. PMID 16194900. Research Blogging.